Lunit , a leading provider of AI for cancer diagnostics and therapeutics, announced that Volpara Health Technologies will now operate under the Lunit brand, introducing
Incyte announced the expansion of its Moments of Clarity program, which amplifies the voices of people living with chronic immune-mediated skin conditions. This year, the initiative introduces
It might feel like a smart swap: choosing diet soda or a zero‑calorie snack to avoid sugar. But what if artificial sweeteners speeding up brain
Aceso Interactive, Inc., a leading provider of healthcare communication and patient engagement technology, has announced a strategic partnership with Samsung Electronics America to deliver advanced
Jopari Solutions, a leading healthcare technology company specializing in electronic billing, attachments, and payment solutions, has announced the appointment of John Gilmartin as President. Gilmartin,
Locumsmart, the first vendor management system in the healthcare industry designed exclusively for locum tenens staffing, has announced the promotion of Thomas Lanvers to the
Press Ganey, a leader in experience measurement, analytics, and advisory services for health systems and health plans, has released its Healthcare Consumer Experience 2025 report.
UroViu Corporation has announced that its cystoscope and hysteroscope product portfolio has received CE certification. The certification covers the reusable UV5000w Wi-Fi Handle as well
FillPoint Health, a Lyceum Health company and an accredited specialty pharmacy and MSO, has announced a strategic partnership with Noble, an Aptar Pharma company recognized
Fresenius Kabi, a division of the global healthcare company Fresenius and a leading provider of essential medicines and medical technologies, has announced a voluntary nationwide
Organon, a global healthcare company committed to delivering impactful medicines and solutions, has announced an agreement to sell its JADA System to Laborie Medical Technologies,
Gilead Sciences, Inc. shared new long‑term data reinforcing the safety and effectiveness of Livdelzi (seladelpar) for people living with Primary Biliary Cholangitis (PBC). The findings
